Document Classification

Section Type: METHODS

Text: Women with stage T1-3N0M0 or T1-2N1M0 breast cancer completely resected by tumorectomy (BCS) or by mastectomy (MA) who consented to participate were randomized, according to a prescribed computer-generated randomization schedule, between control arm of CR 25x2 Gy/5 weeks by tangential fields on breast/chest wall, plus supraclavicular-axillary field if node-positive, and sequential boost 8x2 Gy/2 weeks if BCS (cumulative dose 66 Gy/7 weeks), versus experimental TT arm of 15x2. 8 Gy/3 weeks, including nodal areas if node-positive and simultaneous integrated boost of 0. 6 Gy if BCS (cumulative dose 51 Gy/3 weeks).